| Mannitol | INACTIVE INGREDIENT | 3OWL53L36A | PANTOPRAZOLE SODIUM | 5 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | Eaudeleman Cosmetic Co.; Ltd | 3165 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | Eaudleman Cosmetic Co.; Ltd | 3163 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | These highlights do not include all the information needed to use donepezil hydrochloride orally disintegrating tablets USP safely and effectively. See full prescribing information for donepezil hydrochloride orally disintegrating tablets USP. DONEPEZIL hydrochloride orally disintegrating tablets, USP Initial U.S. Approval: 1996 | 31 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | These highlights do not include all the information needed to use PANTOPRAZOLE sodium delayed-release tablets, USP safely and effectively. See full prescribing information for PANTOPRAZOLE sodium delayed-release tablets, USP. PANTOPRAZOLE sodium delayed-release tablets, USP, for oral administration Initial U.S. approval: 2000 | 11 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | These highlights do not include all the information needed to use AMLODIPINE and VALSARTAN safely and effectively. See full prescribing information for AMLODIPINE and VALSARTAN. AMLODIPINE and VALSARTAN (AMLODIPINE and VALSARTAN) TABLET for ORAL use. Initial U.S. Approval: 2007 | 5 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP . OMEPRAZOLE Delayed-Release Capsules, USP , for oral use INITIAL U.S. APPROVAL: 1989 | 15 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | These highlights do not include all the information needed to use RECOTHROM safely and effectively. See full prescribing information for RECOTHROM. RECOTHROM, Thrombin topical (Recombinant) Lyophilized Powder for Solution - For Topical Use Only Initial U.S. Approval: 2008 | 8 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL TABLETS, USP Rx only | 18 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL TABLETS, USP Rx only | 18 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | These highlights do not include all the information needed to use gemcitabine for injection safely and effectively. See full prescribing information for gemcitabine for injection. Gemcitabine For Injection, Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 1996 | 5 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | These highlights do not include all the information needed to use Escitalopram Tablets USP safely and effectively. See full prescribing information for Escitalopram Tablets USP. Initial U.S. Approval: 2002 | 5 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | These highlights do not include all the information needed to use VIBATIV ® (telavancin) safely and effectively. See full prescribing information for VIBATIV. VIBATIV ® (telavancin) for injection, for intravenous use Initial U.S. Approval: 2009 | 9 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL and HYDROCHLOROTHIAZIDE TABLETS, USP | 6 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | Lisinopril Tablets USP | 12 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | 70015427 Diethylpropion HCl USP C-IV Immediate-Release 25 mg Tablets Diethylpropion HCl USP C-IV Controlled-Release 75 mg Tablets Rx only Rev. March 2007 | 7 | |
| Mannitol | INACTIVE INGREDIENT | 3OWL53L36A | Drug Facts | 17 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | 2cfedf7a-8ec2-4060-a4cf-305c06e03192 | 7 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | Therapentin-90 | 12 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | Lytensopril-90 2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg and 40 mg Rx only | 8 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | Lisinopril Tablets USP | 7 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | Buprenorphine hydrochloride 8mg | 1002 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ONDANSETRON TABLET, ORALLY DISINTEGRATING [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3999 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | GABAPENTIN CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3975 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3953 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ONDANSETRON TABLET, ORALLY DISINTEGRATING [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3925 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | GABAPENTIN CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3890 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | SUBOXONE (BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3832 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | FEXOFENADINE HYDROCHLORIDE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3814 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL TABLET [LAKE ERIE MEDICAL QUALITY CARE PRODUCTS LLC] | 3711 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | SINGULAIR (MONTELUKAST SODIUM) TABLET, CHEWABLE SINGULAIR (MONTELUKAST SODIUM) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3686 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLIES DBA QUALITY CARE PRODUCTS LLC] | 3607 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUTCS LLC] | 3575 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | GABAPENTIN (GABAPENTIN ) CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3480 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | OMEPRAZOLE CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3379 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | PLAVIX (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3378 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | VENLAFAXINE HYDROCHLORIDE TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3320 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | GABAPENTIN CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3306 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3263 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | GENE 16 WHITENING FACTOR (ALLANTOIN) TABLET, SOLUBLE [SHANGHAI LIANG LIANG INTERNATIONAL INC] | 3133 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3055 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | HUMIRA (ADALIMUMAB) KIT HUMIRA (ADALIMUMAB) INJECTION, SOLUTION [ABBVIE INC.] | 1805 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LUPRON DEPOT (LEUPROLIDE ACETATE) KIT [ABBVIE INC.] | 1488 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LUPRON DEPOT (LEUPROLIDE ACETATE) KIT [ABBVIE INC.] | 1450 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LUPRON DEPOT (LEUPROLIDE ACETATE) KIT [ABBVIE INC.] | 1447 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | SUBOXONE (BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE) TABLET [BRYANT RANCH PREPACK] | 1004 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1002 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [BRYANT RANCH PREPACK] | 1001 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | HYOSCYAMINE SULFATE TABLET [BRYANT RANCH PREPACK] | 1001 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL TABLET [BRYANT RANCH PREPACK] | 1001 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL TABLET [BRYANT RANCH PREPACK] | 1001 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | MIRTAZAPINE TABLET, ORALLY DISINTEGRATING [BRYANT RANCH PREPACK] | 1001 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | MONTELUKAST SODIUM TABLET, CHEWABLE [BRYANT RANCH PREPACK] | 1001 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | MONTELUKAST SODIUM TABLET, CHEWABLE [BRYANT RANCH PREPACK] | 1001 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | BRILINTA (TICAGRELOR) TABLET [BRYANT RANCH PREPACK] | 1000 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | BUPRENORPHINE HCL AND NALOXONE HCL (BUPRENORPHINE AND NALOXONE) TABLET [BRYANT RANCH PREPACK] | 1000 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | DULOXETINE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | DULOXETINE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1000 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | FLUVOXAMINE MALEATE TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1000 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [BRYANT RANCH PREPACK] | 1000 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | MIRTAZAPINE TABLET, ORALLY DISINTEGRATING [BRYANT RANCH PREPACK] | 1000 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | MIRTAZAPINE TABLET, ORALLY DISINTEGRATING [BRYANT RANCH PREPACK] | 1000 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | MIRTAZAPINE TABLET, ORALLY DISINTEGRATING [BRYANT RANCH PREPACK] | 1000 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | PANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] | 1000 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] | 1000 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] | 1000 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | SINGULAIR (MONTELUKAST SODIUM) TABLET, CHEWABLE [BRYANT RANCH PREPACK] | 1000 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | SINGULAIR (MONTELUKAST SODIUM) TABLET, CHEWABLE [BRYANT RANCH PREPACK] | 1000 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ONDANSETRON TABLET, ORALLY DISINTEGRATING [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 456 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | OMEPRAZOLE CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 430 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | MIRAPEX (PRAMIPEXOLE DIHYDROCHLORIDE) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 415 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 347 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ENBREL (ETANERCEPT) SOLUTION ENBREL (ETANERCEPT) KIT [IMMUNEX CORPORATION] | 165 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | BUPRENORPHINE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) TABLET [REMEDYREPACK INC. ] | 130 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | BUPRENORPHINE HYDROCHLORIDE TABLET [REMEDYREPACK INC. ] | 130 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | NPLATE (ROMIPLOSTIM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [AMGEN INC] | 124 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LUPANETA PACK (LEUPROLIDE ACETATE AND NORETHINDRONE ACETATE) KIT [ABBVIE INC.] | 122 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL TABLET [REMEDYREPACK INC. ] | 83 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LUPANETA PACK (LEUPROLIDE ACETATE AND NORETHINDRONE ACETATE) KIT [ABBVIE INC.] | 76 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL TABLET [REMEDYREPACK INC. ] | 74 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED ISENTRESS (RALTEGRAVIR) TABLET, CHEWABLE ISENTRESS (RALTEGRAVIR) GRANULE, FOR SUSPENSION [MERCK SHARP & DOHME CORP.] | 49 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | SINGULAIR (MONTELUKAST SODIUM) GRANULE SINGULAIR (MONTELUKAST SODIUM) TABLET, CHEWABLE SINGULAIR (MONTELUKAST SODIUM) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.] | 48 | |
| Mannitol | INACTIVE INGREDIENT | 3OWL53L36A | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Mannitol | INACTIVE INGREDIENT | 3OWL53L36A | ALIMTA (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY] | 43 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | TRELSTAR (TRIPTORELIN PAMOATE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION TRELSTAR (TRIPTORELIN PAMOATE) KIT [ACTAVIS PHARMA, INC.] | 40 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL TABLET [MAJOR PHARMACEUTICALS] | 37 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LUPRON DEPOT-PED (LEUPROLIDE ACETATE) KIT [ABBVIE INC.] | 36 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | KUVAN (SAPROPTERIN DIHYDROCHLORIDE) TABLET KUVAN (SAPROPTERIN DIHYDROCHLORIDE) POWDER, FOR SOLUTION KUVAN (SAPROPTERIN DIHYDROCHLORIDE) POWDER, FOR SOLUTION [BIOMARIN PHARMACEUTICAL INC.] | 35 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | AFINITOR (EVEROLIMUS) TABLET AFINITOR DISPERZ (EVEROLIMUS) TABLET, FOR SUSPENSION [NOVARTIS PHARMACEUTICALS CORPORATION] | 34 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | FAZACLO (CLOZAPINE) TABLET, ORALLY DISINTEGRATING [JAZZ PHARMACEUTICALS, INC.] | 33 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL TABLET [INTERNATIONAL LABORATORIES, INC.] | 33 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | 33 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL TABLET [EON LABS, INC.] | 32 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | SUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC] | 31 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL TABLET [REMEDYREPACK INC. ] | 29 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | PRILOSEC (OMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE PRILOSEC (OMEPRAZOLE MAGNESIUM) GRANULE, DELAYED RELEASE [ASTRAZENECA LP] | 29 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [INTERNATIONAL LABORATORIES, INC.] | 28 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | PREVACID (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE PREVACID SOLUTAB (LANSOPRAZOLE) TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 28 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | GABAPENTIN CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 27 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL TABLET [WEST-WARD PHARMACEUTICAL CORP] | 27 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL TABLET [PD-RX PHARMACEUTICALS, INC.] | 26 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) GRANULE, DELAYED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 26 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | SINGULAIR (MONTELUKAST SODIUM) TABLET, CHEWABLE [PD-RX PHARMACEUTICALS, INC.] | 26 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | EFFIENT (PRASUGREL HYDROCHLORIDE) TABLET, FILM COATED [ELI LILLY AND COMPANY
] | 25 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | HUMATROPE (SOMATROPIN) KIT [ELI LILLY AND COMPANY] | 24 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LAMICTAL (LAMOTRIGINE) TABLET LAMICTAL (LAMOTRIGINE) TABLET, CHEWABLE LAMICTAL ODT (LAMOTRIGINE) TABLET, ORALLY DISINTEGRATING LAMICTAL (LAMOTRIGINE) KIT [GLAXOSMITHKLINE LLC] | 24 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [IVAX PHARMACEUTICALS, INC.] | 24 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL TABLET [QUALITEST PHARMACEUTICALS] | 24 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | OMNITROPE (SOMATROPIN) INJECTION, SOLUTION OMNITROPE (SOMATROPIN) KIT [SANDOZ INC] | 24 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ZOMETA (ZOLEDRONIC ACID) INJECTION, SOLUTION, CONCENTRATE [NOVARTIS PHARMACEUTICALS CORPORATION] | 24 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [EISAI INC.] | 23 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | BRILINTA (TICAGRELOR) TABLET [ASTRAZENECA LP] | 23 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | FORTEO (TERIPARATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 23 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | OXYBUTYNIN CHLORIDE EXTENDED RELEASE (OXYBUTYNIN CHLORIDE) TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 23 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | VELCADE (BORTEZOMIB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MILLENNIUM PHARMACEUTICALS, INC.] | 23 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | TEMODAR (TEMOZOLOMIDE) CAPSULE TEMODAR (TEMOZOLOMIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] | 22 | |